We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.8B
AUM Growth
+$1.44B
(+1.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
1,933
New
90
Increased
882
Reduced
857
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$366M |
| 2 |
CarMax
KMX
|
+$273M |
| 3 |
O'Reilly Automotive
ORLY
|
+$240M |
| 4 |
Motorola Solutions
MSI
|
+$212M |
| 5 |
Alibaba
BABA
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$401M |
| 2 |
TechnipFMC
FTI
|
+$399M |
| 3 |
AutoZone
AZO
|
+$327M |
| 4 |
Cisco
CSCO
|
+$232M |
| 5 |
NetEase
NTES
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Energy | 13.48% |
| 4 | Healthcare | 12.91% |
| 5 | Technology | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Sinclair Inc
SBGI
$974M
| $109M | 0.13% |
2,874,958
+706,386
| +33% | +$23.4M |
|
177
Bristol-Myers Squibb
BMY
$127B
| $108M | 0.13% |
1,763,700
-397,466
| -18% | -$24.9M |
|
178
USA Compression Partners
USAC
$3.82B
| $108M | 0.13% |
6,529,518
-42,860
| -0.7% | -$715K |
|
179
AnaptysBio
ANAB
$1.6B
| $107M | 0.13% |
+1,059,381
| New | +$78M |
|
180
Morgan Stanley
MS
$337B
| $107M | 0.13% |
2,031,864
-419,583
| -17% | -$21.2M |
|
|
SPR
181
DELISTED
Spirit AeroSystems
SPR
| $105M | 0.13% |
1,206,325
-189,981
| -14% | -$15.6M |
|
182
Westlake Chemical Partners
WLKP
$777M
| $105M | 0.13% |
4,208,778
+231,254
| +6% | +$5.23M |
|
183
Bruker
BRKR
$9.2B
| $105M | 0.13% |
3,046,162
-158,158
| -5% | -$5.18M |
|
184
Suburban Propane Partners
SPH
$1.23B
| $105M | 0.13% |
4,314,898
-316,224
| -7% | -$7.87M |
|
|
RAD
185
DELISTED
Rite Aid Corporation
RAD
| $104M | 0.13% |
2,645,359
+1,500,410
| +131% | +$53.6M |
|
186
Spectrum Brands
SPB
$2.04B
| $102M | 0.12% |
908,814
+13,215
| +1% | +$1.44M |
|
|
TGP
187
DELISTED
Teekay LNG Partners L.P.
TGP
| $101M | 0.12% |
5,014,317
-52,800
| -1% | -$959K |
|
188
Synchrony
SYF
$23.7B
| $100M | 0.12% |
2,599,717
-193,832
| -7% | -$6.63M |
|
|
APLP
189
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
| $99.5M | 0.12% |
8,358,342
-223,289
| -3% | -$2.8M |
|
|
SCHW
190
Charles Schwab
SCHW
$177B
| $98.6M | 0.12% |
1,920,152
+131,229
| +7% | +$6.16M |
|
191
DXC Technology
DXC
$1.63B
| $98M | 0.12% |
1,193,339
-238,581
| -17% | -$19.3M |
|
192
RTX Corp
RTX
$287B
| $97.9M | 0.12% |
1,219,453
+37,615
| +3% | +$2.86M |
|
193
ExxonMobil
XOM
$651B
| $97.2M | 0.12% |
1,162,610
-195,691
| -14% | -$16.2M |
|
194
Lamar Advertising Co
LAMR
$16.2B
| $97.1M | 0.12% |
1,307,896
-20,094
| -2% | -$1.47M |
|
195
Booking.com
BKNG
$138B
| $96.5M | 0.12% |
1,388,650
+2,775
| +0.2% | +$201K |
|
|
SHLX
196
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $96.4M | 0.12% |
3,231,565
+9,529
| +0.3% | +$259K |
|
197
Constellation Brands
STZ
$22.2B
| $95.5M | 0.12% |
417,851
-21,646
| -5% | -$4.68M |
|
|
SEP
198
DELISTED
Spectra Engy Parters Lp
SEP
| $91.6M | 0.11% |
2,315,751
-305,278
| -12% | -$12.8M |
|
199
Align Technology
ALGN
$12B
| $91.2M | 0.11% |
410,559
-14,179
| -3% | -$3.22M |
|
200
Martin Midstream Partners
MMLP
$95.9M
| $90.1M | 0.11% |
6,437,052
-86,417
| -1% | -$1.3M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2017 Portfolio in Review
As of Q4 2017, OppenheimerFunds held 1,933 positions worth $82.8B, up 1.8% from $81.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q4 2017 filing shows 90 new, 882 increased, 857 reduced and 96 closed positions. Its largest new stake was Nebius Group N.V.: 5,110,710 shares worth $167M. The largest sale was Nektar Therapeutics, an estimated $401M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q4 2017 buy was Nebius Group N.V.: 5,110,710 shares worth $167M.
- OppenheimerFunds added most to eBay in Q4 2017, an estimated $366M increase.
- OppenheimerFunds's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $401M.
- OppenheimerFunds fully exited NetEase in Q4 2017, selling an estimated $181M.
- OppenheimerFunds's ten largest holdings make up 16% of its $82.8B portfolio in Q4 2017.
- OppenheimerFunds opened 90 new positions and closed 96 in Q4 2017.
- OppenheimerFunds's portfolio value rose 1.8% quarter-over-quarter to $82.8B.
Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.